Posted by Michael Wonder on 15 Mar 2021
Confirmation of Technigas US FDA timetable
12 March 2021 - Cyclopharm has provided an update of the US FDA’s timetable in respect of approval of the Company’s new drug application for Technegas.
The US FDA has advised the goal date for completion of its full review of the new drug application is 26 June 2021.
